Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism

References

• Fraenkel L. Thecoma and hyperthecosis of the ovary. J Clin Endocrinol Metab. 1943;3(10):557–559.
   Google Scholar
• McClamrock HD, Bass KM, Adashi EY. Ovarian hyperandrogenism: the role of and sensitivity to gonadotropins. Fertil Steril. 1991;55:73–79.
   Google Scholar
• Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29(2):181–191.
   Google Scholar
• Geist SH, Gaines JA. Diffuse luteinization of the ovaries associated with the masculinization syndrome. Am J Obstet Gynecol. 1942;43(6):975–983.
   Google Scholar
• Culiner A, Shippel S. Virilism and theca-cell hyperplasia of the ovary; a syndrome. J Obstet Gynaecol Br Emp. 1949;56(3):439–445.
   PubMedGoogle Scholar
• Aiman J, Edman CD, Worley RJ, et al. Androgen and estrogen formation in women with ovarian hyperthecosis. Obstet Gynecol. 1978;51(1):1–9.
   PubMed Web of Science ®Google Scholar
• Gressel GM. Ovarian stromal hyperthecosis and hyperandrogenemia refractory to hormonal suppression. Obstet Gynaecol Cases Rev. 2015;2(5):058.
   Google Scholar
• Fienberg R. Familial ovarian hyperthecosis. Am J Obstet Gynecol. 1972;112(2):309–310.
   PubMed Web of Science ®Google Scholar
• Nagamani M, Urban RJ. Increased expression of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage and P450 17alpha-hydroxylase enzymes in ovarian hyperthecosis. Fertil Steril. 1999;71(2):328–333.
   PubMed Web of Science ®Google Scholar
• Nagamani M. Polycystic ovary syndrome variants: hyperthecosis. In: Adashi EY, editor. Reproductive endocrinology, surgery, and technology. Philadelphia (PA): Lippincott‐Raven; 1996. p. 1257–1269.
   Google Scholar
• Adashi EY. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril. 1994;62(1):20–27.
   PubMed Web of Science ®Google Scholar
• Baptiste CG, Battista MC, Trottier A, et al. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2010;122(1-3):42–52.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030. Dec
   PubMed Web of Science ®Google Scholar
• Brown RJ, Joseph J, Cochran E, et al. Type B insulin resistance masquerading as ovarian hyperthecosis. J Clin Endocrinol Metab. 2017;102(6):1789–1791.
   PubMed Web of Science ®Google Scholar
• Willis D, Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab. 1995;80(12):3788–3790.
   PubMed Web of Science ®Google Scholar
• Barbieri RL, Makris A, Ryan KJ. Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca. Obstet Gynecol. 1984;64(3 Suppl):73S–80S.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Jakubowicz DJ. Decreasesin ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 335(9):617–623.
   PubMed Web of Science ®Google Scholar
• Nagamani M, Dinh TV, Kelver ME. Hyperinsulinemia in hyperthecosis of the ovaries. Am J Obstet Gynecol. 1986;154(2):384–389.
   PubMed Web of Science ®Google Scholar
• Yance VV, Marcondes JAM, Rocha MP, et al. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies. Eur J Endocrinol. 2017;177(1):93–102.
   PubMed Web of Science ®Google Scholar
• Zhang C, Sung CJ, Quddus MR, et al. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases. Hum Pathol. 2017;59:120–124.
   PubMed Web of Science ®Google Scholar
• Meserve EE, Crum CP. Stromal hyperthecosis. In: Crum CP, Lee KR, Nucci MR, et al. Diagnostic gynecologic obstetric pathology. 3rd ed. Philadelphia (PA): Elsevier; 2018.
   Google Scholar
• Czyzyk A, Latacz J, Filipowicz D, et al. Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature. Gynecol Endocrinol. 2017;33(11):836–839.
   PubMed Web of Science ®Google Scholar
• Brown DL, Henrichsen TL, Clayton AC, et al. Ovarian Stromal hyperthecosis: sonographic features and histologic associations. J Ultrasound Med. 2009;28(5):587–593.
   PubMed Web of Science ®Google Scholar
• Sasano H, Fukunaga M, Rojas M, et al. Hyperthecosis of the ovary. Clinicopathologic study of 19 cases with immunohistochemical analysis of steroidogenic enzymes. Int J Gynecol Pathol. 1989;8(4):311–320.
   PubMed Web of Science ®Google Scholar
• Goyal A, Malhotra R, Kulshrestha V, et al. Severe hyperandrogenism due to ovarian hyperthecosis in a young woman. BMJ Case Rep. 2019;12(12):e232783.
   PubMedGoogle Scholar
• Goldman JM, Kapadia LJ. Virilization in a postmenopausal woman due to ovarian stromal hyperthecosis. Postgrad Med J. 1991;67(785):304–306.
   PubMed Web of Science ®Google Scholar
• Mamoojee Y, Ganguri M, Taylor N, et al. Clinical case seminar: postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis. Clin Endocrinol. 2018;88(1):13–20.
   PubMed Web of Science ®Google Scholar
• Krug E, Berga SL. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary*1. Obstet Gynecol. 2002;99(5, Part 2):893–897.
   PubMed Web of Science ®Google Scholar
• Barth JH, Jenkins M, Belchetz PE. Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women. Clin Endocrinol. 1997;46(2):123–128.
   PubMed Web of Science ®Google Scholar
• Nagamani M, Hannigan EV, Dinh TV, et al. Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer. J Clin Endocrinol Metab. 1988;67(1):144–148. Jul
   PubMed Web of Science ®Google Scholar
• Carmina E, Dewailly D, Escobar-Morreale HF, et al. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update. 2017;23(5):580–599.
   PubMed Web of Science ®Google Scholar
• Friedman CI, Schmidt GE, Kim MH, et al. Serum testosterone concentrations in the evaluation of androgen-producing tumors. Am J Obstet Gynecol. 1985;153(1):44–49.
   PubMed Web of Science ®Google Scholar
• Braithwaite SS, Erkman-Balis B, Avila TD. Postmenopausal virilization due to ovarian stromal hyperthecosis. J Clin Endocrinol Metab. 1978;46(2):295–300.
   PubMed Web of Science ®Google Scholar
• Goyal A, Kubihal S, Gupta Y, et al. Dynamic testing for evaluation of adrenal and gonadal function in pediatric and adult endocrinology: an overview. Indian J Endocrinol Metab. 2019;23(6):593–601.
   PubMedGoogle Scholar
• Kaltsas GA, Mukherjee JJ, Kola B, Isidori AM, et al. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? Clin Endocrinol. 2003; 59(1):34–43.
   PubMed Web of Science ®Google Scholar
• Rousset P, Gompel A, Christin-Maitre S, et al. Ovarian hyperthecosis on grayscale and color Doppler ultrasound. Ultrasound Obstet Gynecol. 2008;32(5):694–699.
   PubMed Web of Science ®Google Scholar
• Nagamani M, Chilvers R. Ultrasonography and diagnosis of polycystic ovary syndrome. In: Rizk BRMB, editor. Ultrasonography in reproductive medicine and infertility. Cambridge: Cambridge University Press; 2010. p. 75–80.
   Google Scholar
• Rosenkrantz AB, Popiolek D, Bennett GL, et al. Magnetic resonance imaging appearance of ovarian stromal hyperplasia and ovarian hyperthecosis. J Comput Assist Tomogr. 2009;33(6):912–916.
   PubMed Web of Science ®Google Scholar
• Fujii S, Kiyokawa T, Tsukihara S, et al. Magnetic resonance imaging findings of ovarian stromal hyperthecosis. Acta Radiol. 2009;50(8):954–957.
   PubMed Web of Science ®Google Scholar
• Kostakis EK, Gkioni LN, Macut D, et al. Androgens in menopausal women: not only polycystic ovary syndrome. Front Hormone Res. 2019;53;135–161.
   Google Scholar
• Koonings PP, Campbell K, Mishell DR, Jr, et al. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol. 1989;74(6):921–926.
   PubMed Web of Science ®Google Scholar
• Outwater EK, Wagner BJ, Mannion C, et al. Sex cord-stromal and steroid cell tumors of the ovary. Radiographics. 1998;18(6):1523–1546.
   PubMed Web of Science ®Google Scholar
• Hayes MC, Scully RE. Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63 cases. Am J Surg Pathol. 1987;11(11):835–845.
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Abraham GE. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors. Obstet Gynecol. 1979;53(1):36–43.
   PubMed Web of Science ®Google Scholar
• Zhou WB, Chen N, Li CJ. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman. BMC Endocr Disord. 2019;19(1):14.
   PubMedGoogle Scholar
• Vollaard ES, van Beek AP, Verburg FAJ, et al. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin. J Clin Endocrinol Metab. 2011;96(5):1197–1201.
   PubMed Web of Science ®Google Scholar
• Adashi EY. Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism. Fertil Steril. 1990;53(5):765–779.
   PubMed Web of Science ®Google Scholar
• van der Sluis IM, Boot AM, Krenning EP, et al. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J Clin Endocrinol Metab. 2002;87(2):506–512. Feb PMID: 11836277.
   PubMed Web of Science ®Google Scholar
• Ovarian hyperthecosis – UpToDate. 2020. [cited 12 Aug 2020]. https://www.uptodate.com/contents/ovarian-hyperthecosis.
   Google Scholar
• Rezai P, Lui P. Pregnancy after unilateral oophorectomy in a woman with hyperthecosis ovarii. A case report. J Reprod Med. 1994;39(9):729–732. PMID: 7807488.
   PubMed Web of Science ®Google Scholar
• Lozoya Araque T, Monfort Ortiz IR, Martín González JE, et al. Ovarian stromal hyperplasia: a rare cause of postmenopausal hyperandrogenism. J Menopausal Med. 2020;26(1):39–43.
   PubMedGoogle Scholar
• Pelusi C, Forlani G, Zanotti L, et al. No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours. Clin Endocrinol. 2013;78(4):533–538.
   PubMed Web of Science ®Google Scholar
• Rocha T, Crespo RP, Yance VVR, et al. Persistent poor metabolic profile in postmenopausal women with ovarian hyperandrogenism after testosterone level normalization. J Endocr Soc. 2019;3(5):1087–1096.
   PubMed Web of Science ®Google Scholar